Risk Assessment in Adult T-Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation

• Previously examined factors associated with HCT, were not prognostic.• A total of 824 patients were retrospectively examined in this study.• HCT-CI is useful pre-transplant prognostic factors for patients with ATL.• Newly developed ATL HCT-PI may have better prognostic value for patients w ith ATL.

http://www.bbmt.org/article/S1083-8791(17)30819-4/fulltext?rss=yes

Source: Biology of Blood and Marrow Transplantation - November 16, 2017 Category: Hematology Authors: Makoto Yoshimitsu, Ryuji Tanosaki, Koji Kato, Takashi Ishida, Ilseung Choi, Yoshifusa Takatsuka, Takahiro Fukuda, Tetsuya Eto, Michihiro Hidaka, Naoyuki Uchida, Toshihiro Miyamoto, Yasuhiro Nakashima, Yukiyoshi Moriuchi, Koji Nagafuji, Yasuhiko Miyazaki, Source Type: research